The OTC market is home to stocks of companies trading for pennies. While the stocks can be volatile, they present tremendous opportunities for high-risk tolerant investors eyeing the next breakout king. Some of the stocks in the segment hold the potential for remarkable growth owing to their revolutionary products, services and game-changing technologies.
EPAZ, DPLS, PLPL, and BDPT are some of the OTC stocks threatening to breakout after a long period of consolidation.
Epazz Taps Artificial Intelligence-Powered Drones Attract Strong Interest
Epazz, Inc. (OTC: EPAZ) is one of the stocks trading for pennies that's been attracting lots of interest and buzz owing to its extensive portfolio that spans various industries. Having made a name for itself as a provider of customized cloud applications for corporate companies, education institutions, and the public sector, it's also making inroads into the world of Artificial Intelligence (AI), a technology it uses to enhance its drone technology.
With the drone industry evolving thanks to technological advancement and strong demand from various sectors, there is a tremendous opportunity that EPAZZ plans to unlock with its drone technology. Its cutting-edge autonomous drone, ZenaDrone 1000, has received positive feedback from various industries, including the military, agriculture, oil, and gas industries. The drone is designed for surveillance, inspection, and monitoring purposes.
Dr. Shaun Passley, the CEO of Epazz, commented on the company's technological advancements, stating, "When we embarked on the drone project back in 2019, we couldn't have anticipated the diverse range of technologies we would need to create. As the project progressed, new opportunities emerged. We are now evaluating the best ways to monetize our technological advancements and create value for our company."
Likewise, Epazz and its subsidiary ZenaDrone have started pursuing commercial applications for its drone technology as it looks to unlock value. It is currently in negotiations for the use of the technology in the agriculture sector in Ireland, in addition to businesses and government agencies.
Significant interest from the US military underscores the prowess and the edge that the ZenaDrone 1000 has over other drones in the industry. The drone has especially been tested for delivering sensitive cargo applications and blood transportation with much success. The strong interest serves as solid validation expected to unlock new opportunities.
Epazz has also filed its first patent on artificial intelligence through its smart battery technology subsidiary, Galaxy Batteries. The patent covers using AI smart battery technology to collect environmental data, including wind speed, humidity, and pressure.
CEO Shaun Passley, PhD, said, "We are excited to be filing our first patent for Galaxy Batteries, Inc. The technology will focus on ZenaDrone 1000, but can be used for future electric airplanes."
Collecting data makes it easy to predict the best output for a system to perform maximum flight time and calculate the devices' maximum battery duration or battery life. Following the patent filings, Epazz has already started evaluating how to monetize the varied technologies best. The ultimate goal is to find ways to provide value for the company.
The patent filing comes from Epazz working on special battery technologies for high-powered devices and aircraft. There are already plans to file patents for other battery technologies as part of an effort to build a robust IP portfolio.
The drone technology company has already developed a process that increases the flight of its ZenaDrone 1000 expected to provide another opportunity to file for new patents. EPAZ has been using artificial intelligence technology to push its drone technology to a whole new level
DarkPulse Inc Partners with Keystone Global to Pursue Growth Opportunities
DarkPulse, Inc. (OTC: DPLS) Inc is making a mark as a technology company focused on developing, marketing, and distributing a suite of engineering, installation, and security management solutions. Early this year, it engaged Keystone Global Holdings, a full-service construction and infrastructure advisory firm, to pursue growth opportunities.
As an emerging company, DarkPulse seeks to pursue growth opportunities in the infrastructure sector. Keystone's ability to provide strategic capital should come in handy in executing the rapidly growing demand for proprietary technologies and services in the private and public sectors.
The pursuit of opportunities in the infrastructure industry is supported by an advanced laser-based monitoring system that DarkPulse uses to rapidly and accurately monitor temperatures, strains, and stresses. The technology is increasingly being used in advanced structural monitoring of infrastructure in Smart Cities.
Currently, DarkPulse offers the technology in 20 different countries. There are plans to make the technology available in other countries in pursuit of new opportunities while also helping improve human conditions. The technology application is massive as it can be applied in buildings and other industrial infrastructure.
DPLS is also fresh from signing a Master Service Agreement with a huge manufacturer with a global footprint. The agreement is for manufacturing up to 200 hardware units while also helping design changes and upgrades. The next step from the agreement is a purchase order that should strengthen the DPLS revenue base.
Plandai Unlocking Growth Opportunities with bCOOL Technology
Plandai Biotechnology, Inc. (OTC: PLPL) has made a name for itself in producing and distributing botanical extracts for the nutraceutical and pharmaceutical industries. It also has an interest in the disinfectant and cleaning technology sector through its wholly-owned subsidiary ByoPlanet
ByoPlanet remains the key driver of value backed by its groundbreaking bCool cooling technology. The technology stands out in revolutionizing heat-related conditions by spraying a thin layer of water, keeping athletes cool, and enhancing their performance. Several major league and college sports organizations are already using the technology.
The New York Yankees, Tampa Bay Rays, and Toronto Blue Rays are some major league teams utilizing the technology to enable athletes to enjoy the benefits of cool water regardless of the initial temperature. bCool technology is also finding use in the firefighting business, and firefighters and first responders use it after exiting intense fire scenes. The major heat waves in the summer will provide a major market for bCOOL technology in the commercial and domestic sectors.
Additionally, Plandai, through ByoPlanet, has inked a strategic partnership with the United States Equestrian Federation to advance animal health. The agreement will pair the cooling solutions with Merck Animal Health's leading antimicrobic products to enhance pathogen control in the equine industry.
Bioadaptive, Inc Sets Sights in Global Botanical Market
Bioadaptives, Inc. (OTC: BDPT), a manufacturer and distributor of natural plant and algal-based products that improve health and wellness for humans and animals, has been volatile in the market. The heightened volatility coincides with the announcement that the company will spin off its Livestock Impact Division
The new wholly-owned unit specializes in developing and marketing natural supplements for performance animals and pets. It will also expand its operations to pursue new opportunities around botanical drugs for veterinary and human use.
Bioadaptives is positioning the new subsidiary to pursue opportunities in the global botanical drug market expected to be worth $3.2 billion by 2030. With the market growing at a compound annual growth rate of 39%, there are tremendous opportunities for growth.
Favorable regulatory frameworks in key markets of India, Australia, and South Korea should continue to create new opportunities for the global botanical drugs market. Additionally, BDVT entered into an exclusive license agreement with LY Research.
The agreement paves the way for the marketing of the patented resveratrol product, a move expected to expand Bioadaptive's footprint into the US veterinary market valued at $6.85 billion in 2020 and expected to reach $13.76 billion in 2031. The patented supplement offers an array of health benefits due to its anti-inflammatory and antioxidant properties that benefit both humans and animals.
Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) is owned by RazorPitch Inc. and has been retained by Epazz Inc. to assist in the production and distribution of content. 'CGR' is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport/RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR/RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Please visit CapitalGainsReport.com/Disclaimer for full disclaimer.
CapitalGainsReport
Mark McKelvie
Editor
Markrmckelvie@gmail.com
585-301-7700
.
EPAZZ, INC. 
